ScholarIQanswers from OpenAlex

Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy

PaperCitations, authors & open-access status

Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy have?

ScholarIQcitation count

Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy has 4 citations in the OpenAlex counts ScholarIQ stores.

When was Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy published?

ScholarIQyear

Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy has 2024 year in the ScholarIQ index.

What is the open-access status of Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy?

ScholarIQoa status

Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy has closed oa status in the ScholarIQ index.

What is the DOI of Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy?

ScholarIQdoi

The DOI for Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy is on the source record.

What is the PMID of Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy?

ScholarIQpmid

The PMID for Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy is on the source record.

What is the OpenAlex record for Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy?

ScholarIQopenalex

The OpenAlex for Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial